HGH, Growth Hormone Insensitivity Syndromes.Rosenfeld RG, Buckway CK. Department of Pediatrics, Oregon Health Sciences University, Portland, Oreg 97201, USA. rosenfer@ohsu.edu The concept of growth hormone (GH) insensitivity has evolved since the condition was originally identified in 1966, and we now know that the primary defect involved is in the GH receptor. Cloning of the receptor molecule has led to great progress in our understanding of GH insensitivity (GHI) and its therapy, including the roles of GH and insulin-like growth factor I (IGF-I) in growth and development, and the relationships between height and serum levels of GH, IGF-I and their binding proteins. Despite the success of work on GHI and IGF-I, a number of opportunities have been missed in the past. The differences between the metabolic effects of GH and IGF-I are not fully understood, while measurements of IGF-I and IGF-binding protein 3 are perhaps not the ideal means of diagnosing GHI. Finally, the use of IGF-I to treat GHI has a number of limitations, and work is underway to develop alternative therapies. Copyright 2001 S. Karger AG, Basel Publication Types:
Read about herbal HGH products Click here to Buy HGH Human Growth Hormone
|
Terms of Use - Privacy
Policy
Disclaimer: Content on this site is
for reference purposes and is not intended to substitute for
advice given by a physician, pharmacist, or other licensed
health-care professional. You should not use this information as
self-diagnosis or for treating a health problem or disease.
Links and content located on other sites is not our
responsibility. Do your own due diligence before purchasing any
product. Contact your health-care provider immediately if you
suspect that you have a medical problem. Information and
statements regarding dietary supplements have not been evaluated
by the Food and Drug Administration and are not intended to
diagnose, treat, cure, or prevent any disease or health
condition.